Physician profile
Taryn Smith
NPI 1134465081
$1,203.50
in general payments reported to CMS, 2019-2025
16 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $668 · 2022: $426 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $109.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $278.03 | 2021-2022 | |
| Medtronic, INC. | $201.48 | 2021-2025 | Interstim |
| Abbvie INC. | $139.09 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $87.34 | 2021-2022 | |
| Astellas Pharma US INC | $81.46 | 2021-2022 | |
| Therapeuticsmd, INC. | $63.60 | 2021 | |
| Pfizer INC. | $63.10 | 2021-2025 | |
| Urovant Sciences INC | $58.54 | 2021-2022 | |
| Allergan, INC. | $52.62 | 2021 | |
| Sumitomo Pharma America, INC. | $47.74 | 2025 | Gemtesa |
| Coloplast Corp | $34.84 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $27.36 | 2025 | |
| Exeltis, USA INC. | $18.89 | 2021 | |
| Mayne Pharma Commercial LLC | $17.38 | 2022 | |
| Hologic Sales and Service, LLC | $16.62 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $15.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taryn Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.